Jena, Germany
EMD Pharmaceuticals, the U.S. subsidiary of Darmstadt, Germany-based Merck KGaA, will construct a $300-million biomanufacturing plant in Jena, Germany. The 200,000-sf facility will manufacture cancer drugs.
The leader in facility planning and space strategy conferences
